✦ LIBER ✦

Fibrosis as an End Point for Clinical Trials in Liver Disease: A Report of the International Fibrosis Group

✍ Scribed by McHutchison, John; Poynard, Thierry; Afdhal, Nezam

Book ID: 122469713
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 561 KB
Volume: 4
Category: Article
ISSN: 1542-3565
DOI: 10.1016/j.cgh.2006.07.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Change in Sweat Chloride as a Clinical E

Change in Sweat Chloride as a Clinical End Point in Cystic Fibrosis Clinical Trials

✍ Durmowicz, Anthony G.; Witzmann, Kimberly A.; Rosebraugh, Curtis J.; Chowdhury, 📂 Article 📅 2013 🏛 American College of Chest Physicians 🌐 English ⚖ 643 KB

First Bacterial Infection as an Alternat

First Bacterial Infection as an Alternative Clinical End Point for Regulatory Approval of Agents Targeting the Primary Cystic Fibrosis Defect

✍ Donald R. VanDevanter 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 76 KB

Ultrasound Evaluation of Liver Disease i

Ultrasound Evaluation of Liver Disease in Cystic Fibrosis as Part of an Annual Assessment Clinic: A 9-year Review

✍ Stuart M. Williams; Robin Goodman; Anne Thomson; Kieran McHugh; David R.M. Linds 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Disease-free survival as an end-point in

Disease-free survival as an end-point in the treatment of solid tumours – Perspectives from clinical trials and clinical practice

✍ Robinson, Andrew G.; Booth, Christopher M.; Eisenhauer, Elizabeth A. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 326 KB

The need for levodopa as an end point of

The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and α-tocopherol

✍ Dr. Peter LeWitt; David Oakes; Lu Cui 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

## Abstract Progression of Parkinson's disease (PD) can be detected through changes in clinical ratings or disability assessments. A clinical trial, Deprenyl and Alpha‐Tocopherol Antioxidative Therapy of Parkinsonism (DATATOP), used a novel study end point: increase in parkinsonian disability to th

Vertebral fracture as an end-point for c

Vertebral fracture as an end-point for clinical trials in osteoporosis: The reliability of digitizing techniques for vertebral area measurements

✍ B.C. Tilley; D.A. Nelson; Ed Peterson; Wm O'Fallon; B.L. Riggs; M. Kleerekoper 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 78 KB